Journals / ENT Updates / 2022 / Cilt: 12 - Sayı: 1

A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis

Pages
29–36
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Introduction: Chondroradionecrosis is a rare and the most severe complication of radiation therapy for laryngeal carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Thirteen cases of laryngeal chondroradionecrosis unresponsive to conservative treatment and treated with laryngectomy were presented with an analysis of possible risk factors.
📊
Key Findings & Data:Methods: Retrospective analysis of 13 patients operated on for chondroradionecrosis was made.
💡
Conclusion & Impact:Introduction: Chondroradionecrosis is a rare and the most severe complication of radiation therapy for laryngeal carcinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Thirteen cases of laryngeal chondroradionecrosis unresponsive to conservative treatment and treated with laryngectomy were presented with an analysis of possible risk factors. Methods: Retrospective analysis of 13 patients operated on for chondroradionecrosis was made. Characteristics of the primary tumor, chondroradionecrosis grade, number of biopsies needed to rule out recurrence, and laryngectomy indications were analyzed. The possible predisposing factors such as alcohol and tobacco use and other major chronic diseases were investigated. Results: All of the patients had a history of smoking. The most common comorbidity was hypertension (46.2%), followed by chronic obstructive pulmonary disease (23.1%). The onset of symptoms was documented within the 10 months following the radiation therapy in 12 of the patients (93.3%) and 12 years after the primary radiation therapy in 1 patient. As the most common symptom, fetor oris was observed in all of the patients, followed by dysphagia (69.2%), hoarseness (61.5%), pain (53.8%), dyspnea (46.2%), and necrotic fistula formation in the anterior neck (15.4%) consecutively. Tumor suspicion (84.6%) was the most common indication for laryngectomy followed by chronic aspiration or feeding disorder (61.5%). Twelve patients were treated with total and 1 with supraglottic laryngectomy. Pectoralis major muscle flap was used in all of the patients for pharyngeal reconstruction or protection against salivary fistula. Conclusion: Diagnosis of chondroradionecrosis is challenging, and tumor recurrence should always be kept in mind. Patients must be informed about the possibility of chondroradionecrosis complications including laryngectomy. Introduction: Chondroradionecrosis is a rare and the most severe complication of radiation therapy for laryngeal carcinoma.

🔖

Cite This Article

BAŞARAN, B., ÇAYTEMEL, B., ŞEN, C., ASLAN, İ., DORUK, C., ÜNSALER, S. (2022). A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. ENT Updates, Cilt: 12 - Sayı: 1, 29–36. https://ajindex.com/articles/501371

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016
  2. 66(1):7-30. [CrossRef] 2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018
  3. 68(6):394-424. [CrossRef] 3. Overgaard J, Mohanti BK, Begum N, et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. Lancet Oncol. 2010
  4. 11(6):553-560. [CrossRef] 4. Al-Mamgani A, van Rooij PH, Woutersen DP, et al. Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients. Clin Otolaryngol. 2013
  5. 38(4):306-312. [CrossRef] 5. Chandler JR. Radiation fibrosis and necrosis of the larynx. Ann Otol Rhinol Laryngol. 1979
  6. 88(4 Pt 1):509-514. [CrossRef] 6. Roh JL. Chondroradionecrosis of the larynx: diagnostic and therapeutic measures for saving the organ from radiotherapy sequelae. Clin Exp Otorhinolaryngol. 2009
  7. 2(3):115-119. [CrossRef] 7. Farneti D, Fabbri C, Prencipe SR. Chondroradionecrosis of the larynx. Curr Opin Otolaryngol Head Neck Surg. 2019
  8. 27(6):463-466. [CrossRef] 8. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006
  9. 24(17):2618-2623. [CrossRef] 9. Keene M, Harwood AR, Bryce DP, van Nostrand AW. Histopathological study of radionecrosis in laryngeal carcinoma. Laryngoscope. 1982
  10. 92(2):173-180. [CrossRef] 10. Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990
  11. 63(751):554-556. [CrossRef] 11. Des Rochers C, Dische S, Saunders MI. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol (R Coll Radiol). 1992
  12. 4(4):214-216. [CrossRef] 12. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008
  13. 26(21):3582-3589. [CrossRef] 13. Miyaguchi M, Takashima H, Kubo T. Laryngeal necrosis after combined chemotherapy and radiation therapy. J Laryngol Otol. 1997
  14. 111(8):763-765. [CrossRef] 14. Phillips TL. Effects of chemotherapy and irradiation on normal tissues. Fro